USCDI and Interoperability Mandates: What MedTech Companies Need to Prepare For

Ask five people at a MedTech company which USCDI version their product needs to support, and you'll often get five different answers. That's not a knowledge gap. It's a structural feature of how USCDI actually works: the "latest published" version and the "currently required" version are rarely the same thing, and the gap between them is exactly where compliance planning goes wrong.

USCDI — the United States Core Data for Interoperability — is the federally maintained baseline data set that certified health IT must be able to exchange. It isn't an API or a file format. It's the vocabulary: which data elements a system has to be able to represent and share, from patient demographics to clinical notes to social determinants of health. ONC updates it roughly annually, and each version adds elements that reflect where clinical and policy priorities have moved.

The version confusion is the real compliance risk

Here's where it gets specific. USCDI v3 became the mandatory certification baseline under ONC's HTI-1 Final Rule as of January 1, 2026 — that's the version that matters for certified health IT today. But ONC finalized USCDI v6 back in July 2025, published a draft v7 in January 2026 with 29 new proposed data elements, and then released the final USCDI v7 in July 2026. Separately, ONC issued USCDI v3.1 after removing certain data elements from v3 following an enforcement discretion decision tied to Executive Order 14168 in March 2025, and a proposed HTI-5 rule from December 2025 would formally adopt that v3.1 baseline. ONC's Standards Version Advancement Process also lets developers voluntarily upgrade to newer versions, including v5, ahead of any mandate.

That's five version numbers in active circulation, each relevant to a different obligation. A MedTech company building for ONC certification needs v3 (or v3.1, pending HTI-5). A company voluntarily adopting ahead of the curve might target v5 or v6. A company tracking where the standard is heading needs to be watching v7. Treating "USCDI compliance" as one fixed target is the single most common planning error we see.

Why this is harder than a standards document suggests

USCDI defines what data should be exchangeable. It says nothing about how that data actually moves between systems — that's the job of FHIR and implementation guides like US Core. So supporting a USCDI version isn't just a data-mapping exercise; it requires FHIR R4 API endpoints validated against the corresponding US Core profile version, tested through tools like Inferno, and typically SMART on FHIR 2.0 authorization for any third-party app connecting to that data.

Layer onto the fact that USCDI compliance obligations don't apply uniformly. ONC's certification requirements bind health IT developers and the scalable Electronic Health Record (EHR) and Clinical Decision Support Systems (CDSS) built for interoperability are primarily designed for healthcare providers, multi-specialty group practices, regional health networks, and large hospital systems, though MedTech companies use them as integration targets. CMS's Interoperability and Prior Authorization Final Rule (CMS-0057-F) requires technology solution partners for health insurance payers to expose FHIR-based prior authorization APIs, with a January 1, 2026 compliance date for parts of that rule.

A MedTech company that isn't itself seeking ONC certification — a digital health startup building on top of certified EHRs, for instance — isn't directly bound by HTI-1, but the systems it integrates with are changing underneath it regardless. Insurance information and care team data that used to require screen-scraping now has a standardized FHIR endpoint, and integration layers built around the old assumption will quietly start returning incomplete data.

What organizations commonly get wrong

Two patterns show up repeatedly. First, treating USCDI compliance as a one-time certification event rather than an annual cycle — a product certified against v3 today will need a plan for v3.1 or a future HTI-5 baseline, and building an update process later is more expensive than designing for annual data-class churn from the start.

Second, underestimating TEFCA. The Trusted Exchange Framework and Common Agreement isn't a legal mandate as of 2026, but CMS has signaled it may become a condition tied to certain program participation in the future, and as more organizations join through Qualified Health Information Networks, non-participating organizations increasingly sit outside a growing default exchange network rather than opting out of a niche one.

What to actually evaluate before the next planning cycle

• Identify which specific regulatory or contractual obligation applies to your organization — ONC certification, a payer's CMS-0057-F deadline, or a trading-partner agreement — and confirm which USCDI version that obligation actually names, rather than assuming "the latest" applies.

• Validate FHIR R4 endpoints against the US Core profile version tied to your required USCDI baseline, using standard test suites, before assuming data-mapping alone satisfies the requirement.

• Build data architecture that treats new USCDI data classes (SDOH, expanded clinical notes, diagnostic imaging metadata) as an expected annual addition, not a one-off migration project.

• Track HTI-5's progress toward finalizing USCDI v3.1 as the near-term certification target, since it directly supersedes today's v3 baseline for enforcement purposes.

• Assess whether TEFCA participation, while not mandatory, is becoming commercially necessary for the trading partners and networks your organization depends on.

Where implementation support actually adds value

Interoperability failures rarely happen at the standards level. They happen in the translation layer — where a legacy system's data model doesn't cleanly map to a new USCDI data class, or where a FHIR API technically exists but returns data too inconsistently structured to be clinically usable. Organizations rebuilding these pipelines benefit from teams that have done FHIR-native integration work across multiple EHR vendors and payer systems, since the edge cases rarely show up in the specification itself.

In the complex world of healthcare, interoperability is more than just standards — it’s about reliable, trustworthy data that clinicians and payers can depend on. The real challenge isn’t whether APIs exist; it’s whether the data they deliver is clean, consistent, and clinically usable.

CitiusTech excels at solving the critical translation layer — transforming raw data from legacy systems into standardized, actionable information. CitiusTech's proven expertise spans multiple EHR vendors and payer systems, enabling seamless integration even in the most complex environments. We understand that many issues arise from edge cases and custom implementations that aren’t covered by standards — and we have the experience to address them.

Partner with CitiusTech to bridge the gap from “API exists” to “data is trustworthy.” Empower your organization to unlock the full potential of interoperability. With CitiusTech’s healthcare and payer interoperability solutions, organizations can accelerate innovation, improve care coordination, and make data-driven decisions with confidence. Turn complex data into your strategic advantage.

The organizations that stay ahead of USCDI aren't the ones that certify against the current version and stop. They're the ones that build the update cycle into their architecture from day one, because the standard was never designed to hold still. To prepare your product ecosystem for upcoming regulatory baselines, contact us to consult with our interoperability experts.